Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13598
Country/Region: Rwanda
Year: 2018
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: USDOD
Total Funding: $970,398 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $970,398
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
TX_NEW 25-29, Male, Positive 2019 19
TX_NEW 30-34, Male, Positive 2019 20
TX_NEW 35-39, Male, Positive 2019 8
TX_NEW 40-49, Male, Positive 2019 4
TX_NEW By Age/Sex: 10-14 Male 2019 2
TX_NEW By Age/Sex: 15-19 Male 2019 8
TX_NEW By Age/Sex: 20-24 Male 2019 19
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 80
TX_NEW Sum of Age/Sex disaggregates 2019 29
VMMC_CIRC 30-34, Male 2019 5,577
VMMC_CIRC 35-39, Male 2019 4,183
VMMC_CIRC 40-49, Male 2019 697
VMMC_CIRC By Age: 10-14 2019 3,485
VMMC_CIRC By Age: 15-19 2019 20,551
VMMC_CIRC By Age: 20-24 2019 5,849
VMMC_CIRC By Age: 25-29 2019 1,906
VMMC_CIRC By circumcision technique: Device-based VMMC 2019 12,674
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 29,573
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 42,248
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 31,791
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 29,885